Physician profile
Russell Freid
NPI 1033195391
$4,057.24
in general payments reported to CMS, 2019-2025
41 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,012 · 2020: $657 · 2021: $1,220 · 2022: $491 · 2023: $373 · 2024: $102 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $373 · Food and Beverage: $269 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $373.33 |
| Food and Beverage | $268.88 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $499.91 | 2019-2022 | |
| Janssen Biotech, INC. | $494.48 | 2019-2025 | Erleada |
| Medtronic, INC. | $373.33 | 2023 | |
| Pfizer INC. | $239.32 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $230.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.98 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $156.76 | 2019-2022 | |
| Amgen INC. | $150.74 | 2019-2021 | |
| Dendreon Pharmaceuticals LLC | $147.79 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $135.97 | 2020-2022 | |
| Boston Scientific Corporation | $135.93 | 2019-2025 | Ams 700 |
| Abbvie INC. | $119.46 | 2019-2022 | |
| Procept Biorobotics Corporation | $112.62 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $102.16 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Astrazeneca Pharmaceuticals LP | $100.09 | 2020-2025 | Imfinzi |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $99.13 | 2021-2022 | |
| Axonics, INC. | $81.25 | 2020-2021 | |
| Antares Pharma, INC. | $79.55 | 2019-2025 | Xyosted |
| Merck Sharp & Dohme LLC | $74.49 | 2020-2021 | |
| Olympus America INC. | $62.31 | 2021-2022 | |
| Urovant Sciences INC | $55.41 | 2021-2022 | |
| Metuchen Pharmaceuticals | $40.90 | 2019-2021 | |
| Neotract INC. | $37.48 | 2019-2020 | |
| Teleflex LLC | $33.55 | 2021-2025 | Urolift |
| Calyxo, INC. | $30.26 | 2025 | Cvac Aspiration System |
| Allergan, INC. | $24.32 | 2019-2020 | |
| Coloplast Corp | $23.96 | 2019 | |
| Convatec INC. | $22.92 | 2021 | |
| Zyla Life Sciences, INC. | $21.89 | 2020 | |
| Travere Therapeutics, INC. | $20.37 | 2019 | |
| Sumitomo Pharma America, INC. | $18.94 | 2025 | Orgovyx |
| Medtronic USA, INC. | $17.93 | 2020 | |
| Ambu INC. | $16.87 | 2020 | |
| 180 Medical, INC. | $16.49 | 2019 | |
| Clarus Therapeutics INC. | $14.70 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.51 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $14.24 | 2019 | |
| Sagent Pharmaceuticals | $13.63 | 2021 | |
| Ferring Pharmaceuticals INC. | $13.26 | 2019 | |
| Photocure INC | $12.34 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Freid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.